At the highest dose, 96% of participants achieved at least 5% weight loss
Considerations: MK-677 causes water retention scale weight commonly increases Strong appetite stimulation community sources describe planning nutrition around it Both compounds are widely reported to improve sleep Blood glucose is commonly monitored (MK-677 can affect insulin sensitivity) Community protocols describe: CJC-1295 (no DAC): 100-300mcg before bed MK-677: 10-25mg once daily (evening preferred) Some community sources describe CJC-1295 DAC weekly + daily MK-677 for convenience Common audience: Users seeking broad GH elevation Users who prefer oral dosing for daily use Hard gainers who benefit from appetite increase Users prioritizing sleep-quality improvements Learn more about CJC-1295 | Learn more about MK-677 Ready to buy
The key is to focus on body composition rather than rapid weight loss
This condition causes stomach and intestine inflammation which leads to vomiting and diarrhea
In response to the UK regulator's warning, 'Novo Nordisk', the manufacturer of Wegovy and Ozempic, stated, "We recommend that patients only use these medications for their approved indications and under the strict supervision of a healthcare professional." 'Eli Lilly', the manufacturer of Mounjaro, said, "The Mounjaro patient information leaflet specifies that acute pancreatitis is an uncommon side effect that may affect up to 1 in 100 people." The MHRA plans to conduct a separate study on patients using GLP-1 class drugs